Foamix Pharmaceuticals Ltd. Deferred Revenue
Foamix Pharmaceuticals Ltd. had Deferred Revenue of $62.00 thousand as of 2017-12-31, per its 10-K filed 2019-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2019-02-28
- 2017-12-31: Deferred Revenue, Current $62.00K.
- 2015-12-31: Deferred Revenue, Current $29.00K.
- 2014-12-31: Deferred Revenue, Current $35.00K.
- 2013-12-31: Deferred Revenue, Current $991.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2017-12-31 | $62.00K 10-K · filed 2019-02-28 |
| 2015-12-31 | $29.00K 20-F · filed 2017-02-21 |
| 2014-12-31 | $35.00K 20-F · filed 2016-03-02 |
| 2013-12-31 | $991.00K 20-F · filed 2015-03-17 |